167 related articles for article (PubMed ID: 11405232)
1. Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form.
Jansen K; Schäfer O; Birkmann E; Post K; Serban H; Prusiner SB; Riesner D
Biol Chem; 2001 Apr; 382(4):683-91. PubMed ID: 11405232
[TBL] [Abstract][Full Text] [Related]
2. The structural transition of the prion protein into its pathogenic conformation is induced by unmasking hydrophobic sites.
Leffers KW; Schell J; Jansen K; Lucassen R; Kaimann T; Nagel-Steger L; Tatzelt J; Riesner D
J Mol Biol; 2004 Nov; 344(3):839-53. PubMed ID: 15533449
[TBL] [Abstract][Full Text] [Related]
3. Physical studies of conformational plasticity in a recombinant prion protein.
Zhang H; Stockel J; Mehlhorn I; Groth D; Baldwin MA; Prusiner SB; James TL; Cohen FE
Biochemistry; 1997 Mar; 36(12):3543-53. PubMed ID: 9132005
[TBL] [Abstract][Full Text] [Related]
4. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
[TBL] [Abstract][Full Text] [Related]
5. Assembly of natural and recombinant prion protein into fibrils.
Leffers KW; Wille H; Stöhr J; Junger E; Prusiner SB; Riesner D
Biol Chem; 2005 Jun; 386(6):569-80. PubMed ID: 16006244
[TBL] [Abstract][Full Text] [Related]
6. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
[TBL] [Abstract][Full Text] [Related]
7. Preventing misfolding of the prion protein by trimethylamine N-oxide.
Bennion BJ; DeMarco ML; Daggett V
Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
[TBL] [Abstract][Full Text] [Related]
8. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
Leliveld SR; Stitz L; Korth C
Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
[TBL] [Abstract][Full Text] [Related]
9. In vitro conversion and seeded fibrillization of posttranslationally modified prion protein.
Stöhr J; Elfrink K; Weinmann N; Wille H; Willbold D; Birkmann E; Riesner D
Biol Chem; 2011 May; 392(5):415-21. PubMed ID: 21476870
[TBL] [Abstract][Full Text] [Related]
10. Effects of detergents on the secondary structures of prion protein peptides as studied by CD spectroscopy.
Kuroda Y; Maeda Y; Sawa S; Shibata K; Miyamoto K; Nakagawa T
J Pept Sci; 2003 Apr; 9(4):212-20. PubMed ID: 12725242
[TBL] [Abstract][Full Text] [Related]
11. Spectroscopic characterization of conformational differences between PrPC and PrPSc: an alpha-helix to beta-sheet transition.
Baldwin MA; Pan KM; Nguyen J; Huang Z; Groth D; Serban A; Gasset M; Mehlhorn I; Fletterick RJ; Cohen FE
Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):435-41. PubMed ID: 7913763
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous and BSE-prion-seeded amyloid formation of full length recombinant bovine prion protein.
Panza G; Stöhr J; Dumpitak C; Papathanassiou D; Weiss J; Riesner D; Willbold D; Birkmann E
Biochem Biophys Res Commun; 2008 Sep; 373(4):493-7. PubMed ID: 18585368
[TBL] [Abstract][Full Text] [Related]
13. Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein.
Hornemann S; Glockshuber R
J Mol Biol; 1996 Sep; 261(5):614-9. PubMed ID: 8800210
[TBL] [Abstract][Full Text] [Related]
14. Curcumin binds to the alpha-helical intermediate and to the amyloid form of prion protein - a new mechanism for the inhibition of PrP(Sc) accumulation.
Hafner-Bratkovic I; Gaspersic J; Smid LM; Bresjanac M; Jerala R
J Neurochem; 2008 Mar; 104(6):1553-64. PubMed ID: 17996023
[TBL] [Abstract][Full Text] [Related]
15. Polypeptide chain folding in the hydrophobic core of hamster scrapie prion: analysis by X-ray diffraction.
Inouye H; Kirschner DA
J Struct Biol; 1998; 122(1-2):247-55. PubMed ID: 9724626
[TBL] [Abstract][Full Text] [Related]
16. Clustered negative charges on the lipid membrane surface induce beta-sheet formation of prion protein fragment 106-126.
Miura T; Yoda M; Takaku N; Hirose T; Takeuchi H
Biochemistry; 2007 Oct; 46(41):11589-97. PubMed ID: 17887730
[TBL] [Abstract][Full Text] [Related]
17. Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization.
Kazlauskaite J; Sanghera N; Sylvester I; Vénien-Bryan C; Pinheiro TJ
Biochemistry; 2003 Mar; 42(11):3295-304. PubMed ID: 12641461
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of the nucleated polymerization model of prion replication.
Rubenstein R; Gray PC; Cleland TJ; Piltch MS; Hlavacek WS; Roberts RM; Ambrosiano J; Kim JI
Biophys Chem; 2007 Feb; 125(2-3):360-7. PubMed ID: 17084016
[TBL] [Abstract][Full Text] [Related]
19. Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity.
Safar J; Roller PP; Gajdusek DC; Gibbs CJ
Protein Sci; 1993 Dec; 2(12):2206-16. PubMed ID: 7905316
[TBL] [Abstract][Full Text] [Related]
20. Characterization of oligomeric species in the fibrillization pathway of the yeast prion Ure2p.
Catharino S; Buchner J; Walter S
Biol Chem; 2005 Jul; 386(7):633-41. PubMed ID: 16207084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]